Residual Weighted Learning for Estimating Individualized Treatment Rules
用于估计个体化治疗规则的残差加权学习AI 解读 ↓
← 返回论文列表与筛选
阅读说明
本页整理公开书目信息，不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成，未完成全文核验，可能有误；具体假设、证明与结论请核对原文。摘要保留来源文本，未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要；缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录，不合计多个记录；关联记录可能包含正式发表版本，不等于此版本单独引用。缺失不视为零，引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配，同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列，再参考通用方法与发表日期。
分类依据与纠错
AI 根据所提供的论文材料归类：摘要以干预后的期望结局为目标，估计和评价个体化治疗分配规则。
反馈分类问题
正在核对关联版本…
代码、数据与补充材料
正在核对对应版本的资源…
用于估计个体化治疗规则的残差加权学习
- 研究问题
- 如何改善结局加权学习对结局平移的敏感性、保留实际治疗分配的倾向及缺少变量选择的问题，以估计个体化治疗规则？
- 方法与思路
- 作者用不含治疗变量的结局回归残差加权分类误差，结合平滑斜坡损失、差分凸优化及线性和非线性规则的变量选择。
- 材料陈述的贡献
- 摘要称给出治疗规则估计的一致性和相对最优规则的期望结局差收敛率，并以模拟及囊性纤维化试验展示表现。
- 阅读关注点
- 核对治疗规则价值的识别条件、残差回归的作用、非凸优化收敛，以及结局平移与变量选择的理论和有限样本证据。
- 阅读边界
- 仅据版本未注明的 OpenAlex 索引摘要，不能推断刊本变化。摘要未说明完整识别条件或收敛率，不能认定所有场景均改善表现。
原文摘要
Personalized medicine has received increasing attention among statisticians, computer scientists, and clinical practitioners. A major component of personalized medicine is the estimation of individualized treatment rules (ITRs). Recently, Zhao et al. (2012) proposed outcome weighted learning (OWL) to construct ITRs that directly optimize the clinical outcome. Although OWL opens the door to introducing machine learning techniques to optimal treatment regimes, it still has some problems in performance. (1) The estimated ITR of OWL is affected by a simple shift of the outcome. (2) The rule from OWL tries to keep treatment assignments that subjects actually received. (3) There is no variable selection mechanism with OWL. All of them weaken the finite sample performance of OWL. In this article, we propose a general framework, called Residual Weighted Learning (RWL), to alleviate these problems, and hence to improve finite sample performance. Unlike OWL which weights misclassification errors by clinical outcomes, RWL weights these errors by residuals of the outcome from a regression fit on clinical covariates excluding treatment assignment. We utilize the smoothed ramp loss function in RWL, and provide a difference of convex (d.c.) algorithm to solve the corresponding non-convex optimization problem. By estimating residuals with linear models or generalized linear models, RWL can effectively deal with different types of outcomes, such as continuous, binary and count outcomes. We also propose variable selection methods for linear and nonlinear rules, respectively, to further improve the performance. We show that the resulting estimator of the treatment rule is consistent. We further obtain a rate of convergence for the difference between the expected outcome using the estimated ITR and that of the optimal treatment rule. The performance of the proposed RWL methods is illustrated in simulation studies and in an analysis of cystic fibrosis clinical trial data.